These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 21594313)

  • 1. Autologous mixed lymphocyte reaction and postoperative prognosis in patients with gastric carcinoma.
    Iwahashi M; Tanimura H; Yamaue H; Tsunoda T; Tani M; Noguchi K; Mizobata S; Tamai M; Hotta T; Arii K; Terasawa H
    Oncol Rep; 1996 Jan; 3(1):45-8. PubMed ID: 21594313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-T cell disturbance causes the suppression of the autologous mixed lymphocyte reaction in patients with gastric carcinoma.
    Iwahashi M; Tanimura H; Yamaue H; Tsunoda T; Tani M; Noguchi K; Mizobata S; Tamai M; Hotta T; Arii K
    Anticancer Res; 1995; 15(3):799-804. PubMed ID: 7645961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Defective autologous mixed lymphocyte reaction (AMLR) in gastric cancer patients].
    Iwahashi M; Tanimura H; Yamaue H; Tsunoda T; Tani M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):63-9. PubMed ID: 2139091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the tumor cell associated glycoconjugate (TCA) derived Kato III, human gastric cancer cells on autologous mixed lymphocyte reaction in patients with rheumatoid arthritis].
    Kashiwagi N; Ochi T
    Ryumachi; 1992 Jun; 32(3):206-14. PubMed ID: 1387980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autoreactive T cell clone generated in the autologous mixed lymphocyte reaction in a patient with gastric carcinoma.
    Iwahashi M; Tanimura H; Yamaue H; Tsunoda T; Tani M; Noguchi K; Mizobata S; Hotta T; Tamai M
    J Clin Lab Immunol; 1993; 40(1):29-37. PubMed ID: 7932625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous mixed lymphocyte reaction in man. XI. Deficiency of autologous mixed lymphocyte reaction and abnormalities of monoclonal antibody-defined T-cell subsets in chronic mucocutaneous candidiasis.
    Gupta S
    Scand J Immunol; 1985 Jun; 21(6):525-30. PubMed ID: 2992070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular interactions in the human T-T autologous mixed lymphocyte reaction.
    Gupta S
    Behring Inst Mitt; 1983 May; (72):101-6. PubMed ID: 6242329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of suppression following autologous mixed lymphocyte reaction; role of a novel 2H4 antigen.
    Takeuchi T; Rudd CE; Schlossman SF; Morimoto C
    Eur J Immunol; 1987 Jan; 17(1):97-103. PubMed ID: 2949986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective autologous mixed lymphocyte reaction (AMLR) and killer activity generated in the AMLR in cancer patients.
    Iwahashi M; Tanimura H; Yamaue H; Tsunoda T; Tani M; Tamai M; Noguchi K; Hotta T
    Int J Cancer; 1992 Apr; 51(1):67-71. PubMed ID: 1532952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self recognition by autologous mixed lymphocyte reaction-primed cells.
    Tomonari K; Wakisaka A; Aizawa M
    J Immunol; 1980 Oct; 125(4):1596-600. PubMed ID: 6447728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responder cells in the human autologous mixed lymphocyte reaction (AMLR). Characterization and interactions in healthy individuals and patients with systemic lupus erythematosus.
    Smolen JS; Siminovitch K; Luger TA; Steinberg AD
    Behring Inst Mitt; 1983 May; (72):135-42. PubMed ID: 6242332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.
    Mizutani Y; Okada Y; Terachi T; Yoshida O
    J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T cells generated in the autologous mixed lymphocyte reaction. I. Primary autologous mixed lymphocyte reaction.
    Tomonari K
    J Immunol; 1980 Mar; 124(3):1111-21. PubMed ID: 6444646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous mixed lymphocyte reaction in man. VI. Deficiency of autologous mixed lymphocyte reaction in type I (insulin-dependent) diabetes mellitus.
    Gupta S; Fikrig S; Orti E
    J Clin Lab Immunol; 1983 Jun; 11(2):59-62. PubMed ID: 6224017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human autologous mixed lymphocyte reaction. I. Suppression by macrophages and T cells.
    Smolen JS; Sharrow SO; Reeves JP; Boegel WA; Steinberg AD
    J Immunol; 1981 Nov; 127(5):1987-93. PubMed ID: 6457858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of the autologous mixed lymphocyte reaction (AMLR) in children splenectomized after trauma.
    Zeman K; Tchórzewski H; Płuzańska A; Chilarski A; Majewska E
    Arch Immunol Ther Exp (Warsz); 1988; 36(5):579-84. PubMed ID: 2908315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of rat autologous mixed lymphocyte reaction with xenogeneic sera and their protein preparations.
    Endho N; Chiba M; Hashimoto Y
    Immunology; 1983 Feb; 48(2):211-7. PubMed ID: 6218071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of primary and secondary autologous mixed lymphocyte reactions by murine alphafetoprotein.
    Hooper DC; Pagida E; Murgita RA
    Oncodev Biol Med; 1982; 3(2-3):151-60. PubMed ID: 6181484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The autologous mixed lymphocyte reaction in cord blood lymphocytes: altered kinetics and magnitude of proliferative response compared to the adult autologous mixed lymphocyte reaction.
    Zamkoff KW; McKenas D; Davey FR
    J Clin Lab Immunol; 1985 Feb; 16(2):87-90. PubMed ID: 3157803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.